Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...
After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be wirelessly interfered with by hackers. Medtronic thinks there’s no evidence that anyone using ...
Medtronic's medical-surgical division accounted for $8.4 billion of total revenue in FY 2023. This division's products span the ... become known for its insulin pump that continually monitors ...
Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...
Medtech giant Medtronic has decided not to go ahead with a planned acquisition of EOFlow, a developer of patch-based insulin pumps, saying that there have been “multiple breaches” of their ...
Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.
Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.
The Sphere-360 study, a prospective, single-arm, multi-center trial with 85 patients in three European centers, showed 81.8% freedom from atrial arrhythmias after one year of follow-up, with 100% ...
Medtronic faced challenges ... Along these lines, it is the market leader in heart devices, insulin pumps, neuromodulators, spinal products, acute care & monitoring, etc. This scale and leadership ...
The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G ... There will continue to be a dire need for products that help simplify the lives of these patients.
Shares of Medtronic PLC MDT advanced 1.52% to $89.47 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...
Medtronic plc (NYSE ... stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company will report its Q2 2025 earnings on November ...